Terapia Nutricional en Pacientes Críticamente Enfermos con COVID-19: Revisión Narrativa

Autores/as

  • Larissa Gens Guilherme Departamento de Nutrição, Universidade Federal de Pernambuco. Recife, Brasil.

DOI:

https://doi.org/10.14306/renhyd.25.S2.1073

Palabras clave:

Terapia nutricional, Estado nutricional, COVID-19, SARS-CoV-2

Resumen

Introducción: La lucha contra la pandemia causada por el Síndrome Respiratorio Agudo Severo Coronavirus 2 (SARS-CoV-2), más conocido como Enfermedad por Coronavirus 2019 (COVID-19), en todos los países del mundo ha sido un desafío. La mayoría de los pacientes pueden ser tratados en aislamiento domiciliario, sin embargo, los pacientes de edad avanzada y/o con comorbilidades asociadas han demostrado condiciones más severas de la enfermedad, que requieren hospitalización, o incluso terapia nutricional y ventilación mecánica. Objetivo: Revisar la evidencia actual para establecer mejores recomendaciones nutricionales para pacientes críticamente enfermos con COVID-19.

Material y métodos: Esta es una revisión narrativa sobre la terapia nutricional en pacientes críticos con COVID-19. Los artículos científicos fueron buscados en las bases de datos U.S. National Library of Medicine (PubMed), así como sus respectivos términos en portugués y inglés, y se eligieron 40 artículos, excluyendo las pautas que se utilizaron para ayudar a redactar mejor este artículo.

Resultados: Los principales hallazgos fueron: La edad y las enfermedades no transmisibles se consideran factores de riesgo de mortalidad, siendo las principales hipertensión arterial sistémica y diabetes mellitus. Estos pacientes necesitan cuidados especiales, así como una evaluación constante del estado nutricional, ya que los pacientes desnutridos y com obesidad han mostrado una alta asociación con la mortalidad y el uso de ventilación mecánica. La terapia nutricional en los pacientes afectados puede mejorar el resultado clínico y debe considerarse como un tratamiento de primera línea y ser más valorado en el entorno hospitalario. Aunque no hay ninguna recomendación para la suplementación de la vitamina C y D y del zinc mineral, éstos pueden traer ventajas al sistema inmune de estos pacientes y ayudar en un mejor pronóstico de COVID-19. Sin embargo, son necesarios más estúdios para corroborar la correcta dosificación.

Conclusiones:Se necesitan más estudios, pero es importante llevar estos temas ya expuestos por algunos autores para estimular discusiones que puedan conducir a mejoras en la estandarización de los enfoques nutricionales.

Citas

(1) Campos LF, Barreto PA, Ceniccola GD, Gonçalves RC, de Matos LBN, Zambelli CMSF, et al. Parecer BRASPEN/ AMIB para o enfrentamento do COVID-19 em pacientes hospitalizados. BRASPEN J. 2020; 35(1): 3-5.

(2) Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020.

(3) Rastreador do COVID-19. Available in: https://bing.com/covid. Acess in July 12, 2020.

(4) Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS Negl Trop Dis. 2020; 14(5): e0008280.

(5) Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-1069.

(6) Martindale R, Patel JJ, Taylor B, Warren M, McClave SA. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. ASPEN. 2020. Available in: https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/Nutrition%20Therapy%20COVID-19_SCCM-ASPEN.pdf. Acess in July 18, 2020.

(7) Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019; 38(1):48-79.

(8) Pedersen HP, Hildebrandt T, Poulsen A, Uslu B, Knudsen HH, Roed J, et al. Initial experiences from patients with COVID-19 on ventilatory support in Denmark. Dan Med J. 2020; 67(5): 1-4. A04200232.

(9) Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581.

(10) Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020; 395(10239):1763-1770.

(11) Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis. 2020; 20(1):427.

(12) Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020.

(13) Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.

(14) Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care. 2020; 24(1):219.

(15) Koh J, Shah SU, Chua PEY, Gui H, Pang J. Epidemiological and Clinical Characteristics of Cases During the Early Phase of COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020; 7:295.

(16) Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-95.

(17) Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538.

(18) Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiol Infect. 2020; 148: e106.

(19) Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020; 130(4):304-309.

(20) Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis, and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1- 11.

(21) Rodriguez-Morales A, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis.2020; 34:101623.

(22) Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049-6057.

(23) Espinosa OA, Zanetti AS, Antunes EF, Longhi FG, Matos TA, Battaglini PF. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med Trop Sao Paulo. 2020; 62: e43.

(24) Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Clin Virol. 2020; 127:104371.

(25) Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care. 2020; 24(1):389.

(26) Tahvildari A, Arbabi M, Farsi Y, Jamshidi P, Hasanzadeh S, Calcagno TM, et al. Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series. Front Med (Lausanne). 2020; 7:231.

(27) Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020; 8(1). pii: e001343.

(28) Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31(6):1068-1077.e3.

(29) Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369:m1985.

(30) Quah P, Li A, Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care. 2020; 24(1):285.

(31) Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020; 201(11):1372-1379.

(32) Li T, Zhang Y, Gong C, Wang J, Liu B, Shi L, et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr. 2020.

(33) Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5(7):667-678.

(34) Kumar VCS, Mukherjee S, Harne PS, Subedi A, Ganapathy MK, Patthipati VS, et al. Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol. 2020; 7(1): e000417.

(35) Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020; 8(2): e000406.

(36) Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, at al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARSCoV- 2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020; 15(6): e0234765.

(37) Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020.

(38) Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020; 24(1):255.

(39) Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; e206775.

(40) Castro MG, Ribeiro PC, Souza IAO, Cunha HFR, Silva MHN, Rocha EEM. Diretriz Brasileira de Terapia Nutricional no Paciente Grave. BRASPEN J. 2018; 33(1): 2-36.

(41) Hasanin A, Mostafa M. Evaluation of fluid responsiveness during COVID-19 pandemic: what are the remaining choices? J Anesth. 2020; 1-7.

(42) Kazory A, Ronco C, McCullough PA. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill. Proc (Bayl Univ Med Cent). 2020; 0(0):1-6.

(43) Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients. 2020; 12(4): 1181.

(44) Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open 2020;10: e039519.

(45) Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020; 92(5):479-490.

(46) Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020; 12(4): 988.

(47) Martucci G, McNally D, Parekh D, Zajic P, Tuzzolino F, Arcadipane A, et al. Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. Crit Care. 2019; 23(1):200.

(48) National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early High-Dose Vitamin D 3 for Critically Ill, Vitamin D-Deficient Patients. N Engl J Med. 2019; 381(26):2529-2540.

Descargas

Publicado

2021-10-10

Cómo citar

Guilherme, L. G. (2021). Terapia Nutricional en Pacientes Críticamente Enfermos con COVID-19: Revisión Narrativa. Revista Española De Nutrición Humana Y Dietética, 25(Supl. 2), e1073. https://doi.org/10.14306/renhyd.25.S2.1073